Summaries of the Section H (HML) update
Each month we issue a summary of the HML update. The table on this page gives a preview of the upcoming changes.
The table on this page gives a preview of the upcoming changes that will be announced in next month’s Section H of the Pharmaceutical Schedule.
The changes will be published in the Online HML(external link) around the 23rd of this month and are effective from next month.
For any questions about these listing changes or the Pharmaceutical Schedule in general, email us at enquiry@pharmac.govt.nz.
18 June 2026 - preview of changes for July 2026
|
Pharmaceutical |
Change |
|---|---|
|
Alfentanil (Medsurge) inj 0.5 mg per ml, 2 ml ampoule |
price decrease and addition of PSS |
|
Bacillus Calmette-Guerin (BCG) (OncoTICE) inj 2-8 × 10ˆ8 CFU vial |
price increase |
|
Benralizumab (Fasenra) inj 30 mg per ml, 1 ml prefilled pen |
new Pharmacode listing (p’code 2731843) |
|
Budesonide with glycopyrronium and eformoterol (Breztri Aerosphere) aerosol inhaler budesonide 160 mcg with glycopyrronium 7.2 mcg and formoterol 5 mcg per dose |
new Pharmacode listing (p’code 2730936) |
|
Calcitonin (Miacalcic) inj 100 iu per ml, 1 ml ampoule |
Pharmacode 2709317 to be delisted 1 October 2026 |
|
Carmustine (BiCNU) inj 100 mg vial |
addition of PSS |
|
Carmustine (BiCNU S29 and Novadoz) inj 100 mg vial |
to be delisted 1 December 2026 |
|
Cefalexin (Cefalexin Sandoz) grans for oral liq 50 mg per ml, 100 ml |
new Pharmacode listing (p’code 2714086) |
|
Chloramphenicol cap 250 mg and 500 mg |
new listing |
|
Cinchocaine hydrochloride with hydrocortisone (Proctosedyl)
|
price increase |
|
Ciprofloxacin (Ipca-Ciprofloxacin) tab 250 mg and 750 mg |
addition of PSS |
|
Ciprofloxacin (Ipca-Ciprofloxacin) tab 500 mg |
price decrease and addition of PSS |
|
Colchicine tab 500 mcg |
Brand change
|
|
Cyclopentolate hydrochloride (Cyclogyl) eye drops 1%, 15 ml |
price increase |
|
Darunavir (Darunavir Viatris) tab 400 mg and 600 mg |
price decrease and addition of PSS |
|
Efavirenz with emtricitabine and tenofovir disoproxil (Tenofovir Efavirenz Emtricitabine (Mylan)) tab 600 mg with emtricitabine 200 mg and tenofovir disoproxil 245 mg (300 mg as a fumarate) |
new listing (p’code 2732041) |
|
Emulsifying ointment (Evara Emulsifying Ointment) oint BP, 500 g |
price decrease and addition of PSS |
|
Ephedrine (Ephedrine Juno) inj 3 mg per ml, 10 ml syringe |
addition of PSS |
|
Ephedrine (Ephedrine Aguettant) inj 3 mg per ml, 10 ml syringe |
delisted 1 July 2026 |
|
Ephedrine (Max Health) inj 30 mg per ml, 1 ml ampoule |
price increase and addition of PSS |
|
Etanercept (Enbrel) inj 25 mg autoinjector, inj 25 mg vial, inj 50 mg autoinjector and inj 50 mg syringe |
amended restriction criteria |
|
Ezetimibe (Ezetimibe Sandoz) tab 10 mg |
price decrease and addition of PSS |
|
Febuxostat (Febuxostat (Teva)) tab 80 mg and 120 mg |
price decrease and addition of PSS |
|
Fluconazole (Diflucan)
|
new listing
|
|
Iodixanol (Visipaque)
|
price increase |
|
Iohexol (Omnipaque)
|
price increase |
|
Lansoprazole (Lansoprazole (Viatris)) tab orodispersible 30 mg |
new listing (p’code 2730200) |
|
Macrogol 3350 with potassium chloride and sodium chloride with/without sodium sulfate, sodium ascorbate, ascorbic acid (Plenvu) powd for oral soln 100g with potassium chloride 1g, sodium chloride 2g and sodium sulfate 9g per sach(1), powd for oral soln 40g with potassium chloride 1.2g and sodium chloride 3.2g per sach(1) and powd for oral soln ascorbic acid 7.54g and sodium ascorbate 48.11g per sach(1) |
addition of PSS |
|
Macrogol 3350 with potassium chloride, sodium bicarbonate and sodium chloride (Movicol) powder for oral soln 13.125 g with potassium chloride 46.6 mg, sodium bicarbonate 178.5 mg and sodium chloride 350.7 mg |
price decrease |
|
Magnesium sulphate (Martindale) inj 2 mmol per ml, 5 ml ampoule |
price decrease and addition of PSS |
|
Mebeverine hydrochloride (Colofac) tab 135 mg |
price decrease and addition of PSS |
|
Melphalan (Melpha) inj 50 mg vial |
price decrease and addition of PSS |
|
Meropenem (Meropenem-AFT) inj 500 mg vial and inj 1 g vial |
price decrease and addition of PSS |
|
Metaraminol (Torbay) inj 10 mg per ml, 1 ml ampoule |
price decrease and addition of PSS |
|
Methotrexate (Methotrexate Pharmascience) inj 7.5 mg prefilled syringe |
new listing (p’code 2733102) |
|
Methylprednisolone aceponate (Advantan) crm 0.1% and oint 0.1%, 15 g |
addition of PSS |
|
Moxifloxacin (Moxifloxacin Kabi) inj 1.6 mg per ml, 250 ml bottle |
price decrease and addition of PSS |
|
Moxifloxacin tab 400 mg |
Brand change
|
|
Multivitamins (Mvite) tab (BPC cap strength) |
price decrease and addition of PSS |
|
Nimodipine (Nimotop) tab 30 mg |
new listing and addition of PSS (p’code 2731568) |
|
Niraparib (Zejula) cap 100 mg |
to be delisted 1 October 2026 |
|
Oxybutynin (Alchemy Oxybutynin) tab 5 mg |
addition of PSS |
|
Paediatric oral feed 1 kcal/ml (Pediasure (chocolate)) liquid 2.8 g protein, 11.2 g carbohydrate and 5 g fat per 100 ml, 200 ml bottle |
Pharmacode change
|
|
Paracetamol (Pacimol) tab 500 mg - blister pack - 1,000 tablet pack |
price decrease and addition of PSS |
|
Paraffin liquid with wool fat (Poly-Visc) eye oint 3% with wool fat 3%, 3.5 g |
new listing (p’code 2718626) |
|
Promethazine hydrochloride (XGen) inj 25 mg per ml, 1 ml ampoule |
new listing (p’code 2733374) |
|
Quetiapine (Quetapel) tab 25 mg, 100 mg, 200 mg and 300 mg |
price decrease and addition of PSS |
|
Rifampicin (Rifadin) inj 600 mg vial |
addition of PSS |
|
Rizatriptan (Rizatriptan Rising) tab orodispersible 10 mg |
new listing (p’code 2733145) |
|
Rizatriptan (Rizamelt) tab orodispersible 10 mg |
price decrease and addition of PSS |
|
Rizatriptan (Rizatriptan Viatris) tab orodispersible 10 mg |
price decrease |
|
Rosuvastatin (Rosuvastatin Mylan) |
new listing
|
|
Simvastatin (Simvastatin Viatris) tab 10 mg, 20 mg, 40 mg and 80 mg |
price decrease and addition of PSS |
|
Sodium citro-tartrate (Ural) grans eff 4 g sachets |
price decrease and addition of PSS |
|
Sunitinib (Sunitinib Rex) cap 12.5 mg, 25 mg and 50 mg |
amended restriction criteria |
|
Suxamethonium chloride (Martindale) inj 50 mg per ml, 2 ml ampoule |
price decrease and addition of PSS |
|
Tamoxifen citrate (Tamoxifen Sandoz) tab 10 mg and 20 mg |
addition of PSS |
|
Temozolomide (Temozolomide (Devatis)) cap 5 mg |
new listing (p’code 2733188) |
|
Temozolomide cap 5 mg (Temaccord, Temozolomide Taro and Temozolomide (Devatis)), cap 20 mg (Temaccord), cap 100 mg (Temaccord), cap 140 mg (Temaccord) and cap 250 mg (Temaccord) |
amended restriction criteria |
|
Tenecteplase inj 50 mg vial |
delisted 1 July 2026 |
|
Tenecteplase (Metalyse) inj 50 mg vial with diluent
|
new listing (p’code 2028743) |
|
Teriflunomide (Teriflunomide Aurobindo) tab 14 mg |
new listing (p’code 2733099) |
|
Testosterone undecanoate inj 250 mg per ml, 4 ml vial
|
Brand change
|
|
Thiamine hydrochloride tab 50 mg |
Brand change
|
|
Triamcinolone acetonide inj 10 mg per ml, 1 ml ampoule (Kenacort-A 10) and inj 40 mg per ml, 1 ml ampoule (Kenacort-A 40) |
addition of PSS |
|
Triamcinolone acetonide (Kenalog in Orabase) paste 0.1%, 5 g |
price decrease and addition of PSS |
|
Tropicamide (Mydriacyl) eye drops 0.5% and 1%, 15 ml |
price increase |
|
Ursodeoxycholic acid (APO-Ursodeoxycholic Acid) cap 250 mg |
new listing (p’code 2729504) |
|
Valaciclovir (Valaciclovir Viatris) tab 500 mg |
new listing (p’code 2725983) |
|
Vancomycin (Vancomycin Viatris) inj 500 mg vial |
Pack size change
|